CTMXCytomX Therapeutics, Inc.
$2.19-48% 1Y
$2.19
$2.1252 weeks$6.75
Valuation
What CTMX's price assumes
CytomX Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 42.5× revenue.
42.5
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 2.09
Price / book · at the end of Sep 2026
Details›
- Price / bookat the end of Sep 2026
- 2.09
- EV / EBIToperating margin −676%: the multiple describes the denominator
- not meaningful
- Market capitalisation218.0 million shares, counted Oct 31, 2026
- $476M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Biotechnology
The closest names by size in the same industry